Indexed keywords
5 (2 CHLOROPHENOXY)TETRAZOLO[1,5 A]QUINAZOLINE;
5 (2 METHOXYPHENOXY)TETRAZOLO[1,5 A]QUINAZOLINE;
5 (2 TOLYLOXY)TETRAZOLO[1,5 A]QUINAZOLINE;
5 (2,4 DICHLOROPHENOXY)TETRAZOLO[1,5 A]QUINAZOLINE;
5 (3 CHLOROPHENOXY)TETRAZOLO[1,5 A]QUINAZOLINE;
5 (3 TOLYLOXY)TETRAZOLO[1,5 A]QUINAZOLINE;
5 (4 CHLOROPHENOXY)TETRAZOLO[1,5 A]QUINAZOLINE;
5 (4 FLUOROPHENOXY)TETRAZOLO[1,5 A]QUINAZOLINE;
5 (4 METHOXYPHENOXY)TETRAZOLO[1,5 A]QUINAZOLINE;
5 (4 TOLYLOXY)TETRAZOLO[1,5 A]QUINAZOLINE;
5 (DECYOXY)TETRAZOLO[1,5 A]QUINAZOLINE;
5 (HEPTYLOXY)TETRAZOLO[1,5 A]QUINAZOLINE;
5 (HEXYLOXY)TETRAZOLO[1,5 A]QUINAZOLINE;
5 (NONYLOXY)TETRAZOLO[1,5 A]QUINAZOLINE;
5 (OCTYLOXY)TETRAZOLO[1,5 A]QUINAZOLINE;
5 (PENTYLOXY)TETRAZOLO[1,5 A]QUINAZOLINE;
5 BUTOXYTETRAZOLO[1,5 A]QUINAZOLINE;
5 ETHOXYTETRAZOLO[1,5 A]QUINAZOLINE;
5 ISOPROPOXYTETRAZOLO[1,5 A]QUINAZOLINE;
5 METHOXYTETRAZOLO[1,5 A]QUINAZOLINE;
5 PHENOXYTETRAZOLO[1,5 A]QUINAZOLINE;
ANTICONVULSIVE AGENT;
ANTIDEPRESSANT AGENT;
FLUOXETINE;
MONOAMINE OXIDASE INHIBITOR;
QUINAZOLINE DERIVATIVE;
UNCLASSIFIED DRUG;
ANIMAL EXPERIMENT;
ANTICONVULSANT ACTIVITY;
ARTICLE;
DRUG STRUCTURE;
DRUG SYNTHESIS;
ELECTRIC SHOCK;
FORCED SWIMMING TEST;
IMMOBILIZATION;
INFRARED RADIATION;
MALE;
MASS SPECTROMETRY;
MOUSE;
NONHUMAN;
PRIORITY JOURNAL;
PROTON NUCLEAR MAGNETIC RESONANCE;
SEIZURE;
STRUCTURE ACTIVITY RELATION;
ANIMALS;
ANTICONVULSANTS;
ANTIDEPRESSIVE AGENTS;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DRUG EVALUATION, PRECLINICAL;
MICE;
MOLECULAR STRUCTURE;
QUINAZOLINES;
STRUCTURE-ACTIVITY RELATIONSHIP;
1
31744436952
Z. S. Quan, J. M. Wang, J. R. Rho, K. C. Kwak, et al., Bull. Korean. Chem. Soc. 2005, 26, 1757-1759.
(2005)
Bull. Korean. Chem. Soc.
, vol.26
, pp. 1757-1759
Quan, Z.S.1
Wang, J.M.2
Rho, J.R.3
Kwak, K.C.4
2
60849119528
X. Y. Sun, L. Zhang, C. X. Wei, H. R. Piao, Z. S. Quan, Eur. J. Med. Chem. 2009, 44, 1265-1270.
(2009)
Eur. J. Med. Chem.
, vol.44
, pp. 1265-1270
Sun, X.Y.1
Zhang, L.2
Wei, C.X.3
Piao, H.R.4
Quan, Z.S.5
3
33748266091
H. G. Jin, X. Y. Sun, K. Y. Chai, H. R. Piao, Z. S. Quan, Bioorg. Med. Chem. 2006, 14, 6868-6873.
(2006)
Bioorg. Med. Chem.
, vol.14
, pp. 6868-6873
Jin, H.G.1
Sun, X.Y.2
Chai, K.Y.3
Piao, H.R.4
Quan, Z.S.5
4
33846010484
X. Y. Sun, G. Li, C. S. Jun, K. Y. Chai, et al., Arch. Pharm. Res. 2006, 29, 1080-1085.
(2006)
Arch. Pharm. Res.
, vol.29
, pp. 1080-1085
Sun, X.Y.1
Li, G.2
Jun, C.S.3
Chai, K.Y.4
5
60549109247
L. J. Guo, C. X. Wei, J. H. Jia, L. M. Zhao, Z. S. Quan, Eur. J. Med. Chem. 2009, 44, 954-958.
(2009)
Eur. J. Med. Chem.
, vol.44
, pp. 954-958
Guo, L.J.1
Wei, C.X.2
Jia, J.H.3
Zhao, L.M.4
Quan, Z.S.5
6
57049130035
L. P. Guan, Q. H. Jin, S. F. Wang, F. N. Li, Z. S. Quan, Arch. Pharm. 2008, 341, 774-779.
(2008)
Arch. Pharm.
, vol.341
, pp. 774-779
Guan, L.P.1
Jin, Q.H.2
Wang, S.F.3
Li, F.N.4
Quan, Z.S.5
7
42049110097
L. P. Guan, G. R. Tian, K. Y. Chai, J. S. Lee , M. S. Song, Z. S. Quan, Turk. J. Chem. 2008, 32, 181-189.
(2008)
Turk. J. Chem.
, vol.32
, pp. 181-189
Guan, L.P.1
Tian, G.R.2
Chai, K.Y.3
Lee, J.S.4
Song, M.S.5
Quan, Z.S.6
8
25144491192
Z. F. Xie, K. Y. Chai, H. R. Piao, C. K. Kyung, Z. S. Quan, Bioorg. Med. Chem. Lett. 2005, 15, 4803-4805.
(2005)
Bioorg. Med. Chem. Lett.
, vol.15
, pp. 4803-4805
Xie, Z.F.1
Chai, K.Y.2
Piao, H.R.3
Kyung, C.K.4
Quan, Z.S.5
9
24944482063
L. J. Cui, Z. F. Xie, H. R. Piao, G. Li, et al., Biol. Pharm. Bull. 2005, 28, 1216-1220.
(2005)
Biol. Pharm. Bull.
, vol.28
, pp. 1216-1220
Cui, L.J.1
Xie, Z.F.2
Piao, H.R.3
Li, G.4
10
60349106858
L. Zhang, L. P. Guan, X. Y. Sun, K. Y. Chai, Z. S. Quan, Chem. Biol. Drug Des. 2009, 73, 313-319.
(2009)
Chem. Biol. Drug Des.
, vol.73
, pp. 313-319
Zhang, L.1
Guan, L.P.2
Sun, X.Y.3
Chai, K.Y.4
Quan, Z.S.5
12
0034049958
S. R. Joca, L. L. Skalisz, V. Beijamini, M. A. Vital, R. Andreatini, Eur. Neuropsychopharmacol. 2000, 10, 223-228.
(2000)
Eur. Neuropsychopharmacol.
, vol.10
, pp. 223-228
Joca, S.R.1
Skalisz, L.L.2
Beijamini, V.3
Vital, M.A.4
Andreatini, R.5
13
38449093258
S. Li, C. Wang, W. Li, K. Koike, et al., J. Asian Nat. Prod. Res. 2007, 9, 421-430.
(2007)
J. Asian Nat. Prod. Res.
, vol.9
, pp. 421-430
Li, S.1
Wang, C.2
Li, W.3
Koike, K.4
14
34249057458
M. P. Kaster, I. Raupp, R. W. Binfaré, R. Andreatini, A. L. Rodrigues, Eur. J. Pharmacol. 2007, 565, 119-124.
(2007)
Eur. J. Pharmacol.
, vol.565
, pp. 119-124
Kaster, M.P.1
Raupp, I.2
Binfaré, R.W.3
Andreatini, R.4
Rodrigues, A.L.5
15
67650230584
X. Y. Sun, L. Zhang, C. X. Wei, H. R. Piao, Z. S. Quan, Pharmacol. Rep. 2009, 61, 245-251.
(2009)
Pharmacol. Rep.
, vol.61
, pp. 245-251
Sun, X.Y.1
Zhang, L.2
Wei, C.X.3
Piao, H.R.4
Quan, Z.S.5
16
1642409766
A. A. Bekhit, O. A. El-Sayed, E. Aboulmagd, J. Y. Park, Eur. J. Med. Chem. 2004, 39, 249-255.
(2004)
Eur. J. Med. Chem.
, vol.39
, pp. 249-255
Bekhit, A.A.1
El-Sayed, O.A.2
Aboulmagd, E.3
Park, J.Y.4
17
0018129707
R. L. Krall, J. K. Penry, B. G. White, H. J. Kupferberg, E. A. Swinyard, Epilepsia 1978, 19, 409-412.
(1978)
Epilepsia
, vol.19
, pp. 409-412
Krall, R.L.1
Penry, J.K.2
White, B.G.3
Kupferberg, H.J.4
Swinyard, E.A.5
18
0021611548
R. J. Porter, J. J. Cereghino, G. D. Gladding, B. J. Hessie, et al., Cleve. Clin. Q. 1984, 51, 293-295.
(1984)
Cleve. Clin. Q.
, vol.51
, pp. 293-295
Porter, R.J.1
Cereghino, J.J.2
Gladding, G.D.3
Hessie, B.J.4
19
0017651126
R. D. Porsolt, A. Bertin, M. Jalfre, Arch. Int. Pharmacodyn. Ther. 1977, 229, 327-336.
(1977)
Arch. Int. Pharmacodyn. Ther.
, vol.229
, pp. 327-336
Porsolt, R.D.1
Bertin, A.2
Jalfre, M.3
20
0036289922
M. Bourin, M. Hascoet, M. C. Colombel, R. T. Coutts, G. B. Baker, J. Psychiatry Neurosci. 2002, 27, 178-185.
(2002)
J. Psychiatry Neurosci.
, vol.27
, pp. 178-185
Bourin, M.1
Hascoet, M.2
Colombel, M.C.3
Coutts, R.T.4
Baker, G.B.5
21
0002537605
(Eds.: S. J. Enna, J. B. Malick, E. Richelson), Raven Press, New York
R. D. Porsolt, in Antidepressants: Neurochemical, Behavioral and Clinical Perspective (Eds.: S. J. Enna, J. B. Malick, E. Richelson), Raven Press, New York 1981, pp. 121-128.
(1981)
Antidepressants: Neurochemical, Behavioral and Clinical Perspective
, pp. 121-128
Porsolt, R.D.1